Apellis Pharmaceuticals, Inc. APLS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

48/100

1/7 Pass

SharesGrow Intrinsic Value

지표	TTM (2025-03 – 2025-12)
매출	$1B
매출총이익	$901.1M
매출총이익률	89.8%
영업이익	$55.43M
순이익	$22.39M
순이익률	2.2%
EPS (희석)	$0.17

다른 사용자도 조회

MDGL

Madrigal Pharmaceuticals, Inc.

$518.58

-1.22%

RXDX

Prometheus Biosciences, Inc.

$199.92

+0.09%

BPMC

Blueprint Medicines Corporation

$129.46

+0.14%

CERE

Cerevel Therapeutics Holdings, Inc.

Terns Pharmaceuticals, Inc.

$52.71

+0.06%

AKRO

Akero Therapeutics, Inc.

$54.65

+0.00%

MRTX

Mirati Therapeutics, Inc.

$58.70

-0.17%

Apellis Pharmaceuticals, Inc. APLS NASDAQ

다른 사용자도 조회

저평가 주식 알림 받기